In this study, we found that the SMAD3 mRNA levels were pathologically upregulated in BC tissues; especially, the mRNA levels of SMAD3 (T/N) were further increased in metastatic BC patients compared with non-metastatic counterparts. Here, SMAD3 is linked to breast cancer.